These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25298143)

  • 1. Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling.
    Shi G; Sun C; Gu W; Yang M; Zhang X; Zhai N; Lu Y; Zhang Z; Shou P; Zhang Z; Ning G
    J Mol Endocrinol; 2014 Dec; 53(3):367-80. PubMed ID: 25298143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2.
    Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ
    Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.
    Fuller M; Priyadarshini M; Gibbons SM; Angueira AR; Brodsky M; Hayes MG; Kovatcheva-Datchary P; Bäckhed F; Gilbert JA; Lowe WL; Layden BT
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E840-51. PubMed ID: 26394664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion.
    Priyadarshini M; Villa SR; Fuller M; Wicksteed B; Mackay CR; Alquier T; Poitout V; Mancebo H; Mirmira RG; Gilchrist A; Layden BT
    Mol Endocrinol; 2015 Jul; 29(7):1055-66. PubMed ID: 26075576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-chain fatty acids and FFAR2 as suppressors of bone resorption.
    Montalvany-Antonucci CC; Duffles LF; de Arruda JAA; Zicker MC; de Oliveira S; Macari S; Garlet GP; Madeira MFM; Fukada SY; Andrade I; Teixeira MM; Mackay C; Vieira AT; Vinolo MA; Silva TA
    Bone; 2019 Aug; 125():112-121. PubMed ID: 31100533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.
    Ang Z; Xiong D; Wu M; Ding JL
    FASEB J; 2018 Jan; 32(1):289-303. PubMed ID: 28883043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Short-Chain Fatty Acid Propionate Inhibits Adipogenic Differentiation of Human Chorion-Derived Mesenchymal Stem Cells Through the Free Fatty Acid Receptor 2.
    Iván J; Major E; Sipos A; Kovács K; Horváth D; Tamás I; Bay P; Dombrádi V; Lontay B
    Stem Cells Dev; 2017 Dec; 26(23):1724-1733. PubMed ID: 28992793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis.
    Mohammad S
    Curr Drug Targets; 2015; 16(7):771-5. PubMed ID: 25850624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APPL1 prevents pancreatic beta cell death and inflammation by dampening NFκB activation in a mouse model of type 1 diabetes.
    Jiang X; Zhou Y; Wu KK; Chen Z; Xu A; Cheng KK
    Diabetologia; 2017 Mar; 60(3):464-474. PubMed ID: 28011992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.
    Nøhr MK; Pedersen MH; Gille A; Egerod KL; Engelstoft MS; Husted AS; Sichlau RM; Grunddal KV; Poulsen SS; Han S; Jones RM; Offermanns S; Schwartz TW
    Endocrinology; 2013 Oct; 154(10):3552-64. PubMed ID: 23885020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free fatty acids receptors 2 and 3 control cell proliferation by regulating cellular glucose uptake.
    Al Mahri S; Al Ghamdi A; Akiel M; Al Aujan M; Mohammad S; Aziz MA
    World J Gastrointest Oncol; 2020 May; 12(5):514-525. PubMed ID: 32461783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by Antibiotics.
    Fuller M; Li X; Fisch R; Bughara M; Wicksteed B; Kovatcheva-Datchary P; Layden BT
    PLoS One; 2016; 11(12):e0167837. PubMed ID: 27959892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of stearoyl-CoA desaturase-1, but not free fatty acid receptor 2 or 4 in subcutaneous adipose tissue of patients with newly diagnosed type 2 diabetes mellitus.
    Bódis K; Kahl S; Simon MC; Zhou Z; Sell H; Knebel B; Tura A; Strassburger K; Burkart V; Müssig K; Markgraf D; Al-Hasani H; Szendroedi J; Roden M;
    Nutr Diabetes; 2018 Sep; 8(1):49. PubMed ID: 30190473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA
    Zhang C; Han X; Yang L; Fu J; Sun C; Huang S; Xiao W; Gao Y; Liang Q; Wang X; Luo F; Lu W; Zhou Y
    Theranostics; 2020; 10(24):10908-10924. PubMed ID: 33042261
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.
    Bjursell M; Admyre T; Göransson M; Marley AE; Smith DM; Oscarsson J; Bohlooly-Y M
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E211-20. PubMed ID: 20959533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening.
    Hatanaka H; Tsukui M; Takada S; Kurashina K; Choi YL; Soda M; Yamashita Y; Haruta H; Hamada T; Ueno T; Tamada K; Hosoya Y; Sata N; Yasuda Y; Nagai H; Sugano K; Mano H
    Cancer Sci; 2010 Jan; 101(1):54-9. PubMed ID: 19780758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
    Pan P; Oshima K; Huang YW; Agle KA; Drobyski WR; Chen X; Zhang J; Yearsley MM; Yu J; Wang LS
    Int J Cancer; 2018 Aug; 143(4):886-896. PubMed ID: 29524208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat.
    Yamamoto I; Kawasumi K; Ohkusu-Tsukada K; Arai T
    Vet Med Sci; 2021 Jan; 7(1):77-85. PubMed ID: 32929853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ffar2 expression regulates leukaemic cell growth in vivo.
    Bindels LB; Porporato PE; Ducastel S; Sboarina M; Neyrinck AM; Dewulf EM; Feron O; Lestavel S; Cani PD; Staels B; Sonveaux P; Delzenne NM
    Br J Cancer; 2017 Oct; 117(9):1336-1340. PubMed ID: 28873082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Treatment with Empagliflozin and GABA Improves
    Daems C; Welsch S; Boughaleb H; Vanderroost J; Robert A; Sokal E; Lysy PA
    J Diabetes Res; 2019; 2019():2813489. PubMed ID: 31467926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.